0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Articles   |    
Mephentermine Psychosis: Misuse of the Wyamine Inhaler
B. M. ANGRIST; J. W. SCHWEITZER; S. GERSHON; A. J. FRIEDHOFF
Am J Psychiatry 1970;126:1315-1317.
View Author and Article Information

Research psychiatrist, department of psychiatry and neurology, New York University Medical Center, 550 First Ave., New York, N.Y. 10016

Instructor in experimental psychiatry, department of psychiatry and neurology, New York University Medical Center, 550 First Ave., New York, N.Y. 10016

Professors of psychiatry, department of psychiatry and neurology, New York University Medical Center, 550 First Ave., New York, N.Y. 10016, director, neuropsychopharmacology research unit, New York University Medical Center

Professors of psychiatry, department of psychiatry and neurology, New York University Medical Center, 550 First Ave., New York, N.Y. 10016

1970, American Psychiatric Association

text A A A
PDF of the full text article.
Abstract

The authors present case reports of three patients with similar pathology in their social, vocational, and sexual adjustment who developed paranoid or paranoid hallucinatory syndromes in conjunction with the abuse of mephentermine from Wyamine inhalers. Their symptomatology appeared clinically identical to amphetamine psychosis or acute paranoid schizophrenia. The authors conclude that, if abused, the Wyamine inhaler is potentially dangerous and that its availability on the market constitutes a loophole in the current regulations governing stimulant drugs.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 8

Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 20.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 20.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 44.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 44.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
PubMed Articles
Mephentermine psychosis: misuse of the Wyamine inhaler. Am J Psychiatry 1970;126(9):1315-7.